Pegasta Injection

Pegasta Injection

3628.0 INR/Pack

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Anti-Bacterial
  • Recommended For Doctor
  • Dosage Guidelines As per Instructions
  • Suitable For Adults
  • Storage Instructions Cool & Dry Place
  • Click to view more
X

Pegasta Injection Price And Quantity

  • 60 Pack
  • 3628.0 INR/Pack

Pegasta Injection Product Specifications

  • As per Instructions
  • Doctor
  • Anti-Bacterial
  • Cool & Dry Place
  • Liquid
  • Injection
  • Adults

Pegasta Injection Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 1000 Pack Per Week
  • 4 Days
  • No
  • If order is confirmed we will reimburse the sample cost
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

1. Technical Specifications:

Attribute Details
Brand Pegasta 6mg Injection
Manufactured By Intas Pharmaceuticals Ltd., India
Packaging Size 6mg pegfilgrastim in 0.6mL prefilled syringe or liquid vial
Packaging Type Single-use syringe or vial in carton
Dosage Form Injectable solution (subcutaneous)
Storage Conditions Refrigerate at 28C; do not freeze; protect from light
Shelf Life Typically 2436 months (check batch expiry)
Regulatory Compliance Manufactured in GMPcertified facility by Intas Pharmaceuticals Ltd.


2. Product Description

Pegasta Injection contains Pegfilgrastim, a long-acting PEGylated recombinant human G-CSF. It stimulates the bone marrow to increase neutrophil production and is used to reduce infection risk (febrile neutropenia) in patients undergoing myelosuppressive chemotherapy. Typically given as a single subcutaneous injection per chemotherapy cycle, about 24hours post-chemotherapy.


3. Product Highlights

Attribute Details
Generic Name Pegfilgrastim
Strength 6mg (in 0.6mL volume)
Dosage Form Ready-to-use liquid (subcutaneous injection)
Therapeutic Category Hematopoietic growth factor / Colony Stimulating Factor
Application Area Prevention of chemotherapy-induced neutropenia
Formulation Sterile solution in prefilled syringe or vial
Storage Conditions 28C refrigerated; avoid freezing and light exposure
Shelf Life Typically 2436 months
Regulatory Compliance Produced in GMPcertified facility by Intas Pharmaceuticals

4. Therapeutic Uses

  • Prevention of febrile neutropenia in non-myeloid malignancy patients receiving chemotherapy.

  • May also be used in acute radiation syndrome for hematopoietic recovery.

5. Safety Profile & Side Effects

Common side effects:

  • Bone or musculoskeletal pain

  • Headache, nausea, fatigue

  • Injection-site discomfort; occasional flushing, rash, or swelling

Rare but serious risks:

  • Splenic rupture

  • Acute respiratory distress syndrome

  • Leukocytosis (elevated white blood cell count)

  • Allergic reactions & capillary leak syndrome

6. Precautions

  • Administer only after approval by healthcare provider and usually 24 hours after chemotherapy.

  • Monitor CBC regularly to track neutrophil count and avoid overshoots.

  • May cause dizziness or concentration issuesadvise caution when driving.

  • Not recommended in pregnancy or while breastfeeding without medical supervision.

  • Avoid interactions with certain chemotherapeutics (e.g., capecitabine, bendamustine) within 14 days.



Targeted Anti-Bacterial Action

Pegasta Injection delivers rapid and targeted anti-bacterial benefits for adults, helping to treat and control infections effectively. Its liquid form allows for efficient absorption when administered by a medical professional.


Professional Handling Required

This medication is recommended strictly for administration by doctors or trained healthcare providers, ensuring precise dosing and monitoring. It is available to medical distributors, exporters, suppliers, traders, and wholesalers across India.


Storage and Handling Precautions

Pegasta Injection must be stored in a cool and dry place to preserve its quality and efficacy. Careful storage helps prevent degradation of the anti-bacterial components, ensuring optimal therapeutic effect upon use.

FAQs of Pegasta Injection:


Q: How should Pegasta Injection be administered?

A: Pegasta Injection must be given by a qualified healthcare provider such as a doctor, following the recommended dosage and administration technique provided by medical guidelines.

Q: What benefit does Pegasta Injection offer?

A: This injection provides strong anti-bacterial action, aiding in the treatment and management of bacterial infections in adults, resulting in improved health outcomes when used as directed.

Q: When is Pegasta Injection recommended?

A: Pegasta Injection is recommended when a doctor diagnoses a bacterial infection that requires injectable antibiotic therapy for adults. The exact timing and frequency are determined by a healthcare professional.

Q: Where should Pegasta Injection be stored?

A: Pegasta Injection should be kept in a cool and dry place, away from direct sunlight, heat sources, and moisture to ensure its effectiveness and shelf life.

Q: What is the proper usage of Pegasta Injection?

A: The injection should only be used as per instructions from a doctor. Self-administration is not advised; always seek medical supervision to ensure accurate dosing and minimize side effects.

Q: Who can receive Pegasta Injection?

A: This medication is intended exclusively for adult patients and must be prescribed and administered by a healthcare professional.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top